BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9989813)

  • 1. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
    Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
    Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
    Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Retinoic acid receptor alpha (RARalpha) chimeric proteins PML-, PLZF-, NPM-, and NuMA-RARalpha have distinct intracellular localization patterns.
    Hummel JL; Zhang T; Wells RA; Kamel-Reid S
    Cell Growth Differ; 2002 Apr; 13(4):173-83. PubMed ID: 11971817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
    Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
    Hong SH; David G; Wong CW; Dejean A; Privalsky ML
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
    Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
    Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
    Guidez F; Parks S; Wong H; Jovanovic JV; Mays A; Gilkes AF; Mills KI; Guillemin MC; Hobbs RM; Pandolfi PP; de Thé H; Solomon E; Grimwade D
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18694-9. PubMed ID: 18000064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
    Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
    Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
    Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
    Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.
    Redner RL; Chen JD; Rush EA; Li H; Pollock SL
    Blood; 2000 Apr; 95(8):2683-90. PubMed ID: 10753851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia.
    Hauksdóttir H; Privalsky ML
    Cell Growth Differ; 2001 Feb; 12(2):85-98. PubMed ID: 11243468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The theory of APL.
    Piazza F; Gurrieri C; Pandolfi PP
    Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.
    Pandolfi PP
    Haematologica; 1996; 81(5):472-82. PubMed ID: 8952164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.